CAY10568 is a cationic lidocaine derivative designed for selective analgesia. Its enhanced permeability through agonist-activated TRPV1 channels allows it to selectively block pain-transmitting neurons while sparing motor and sensory functions, as demonstrated in in vivo pain research models.